All Stories

  1. Sublingual Buprenorphine-Induced Psychomimetic Effects
  2. Substance Use and Dual Diagnosis Disorders: Future Epidemiology, Determinants, and Policies
  3. Is impulsivity in remitted bipolar disorder a stable trait? A meta-analytic review
  4. Serpentine Tongue Syndrome Associated With Risperidone Long-Acting Injection Treatment
  5. Metabolic threshold does not describe it all
  6. Tardive movements and clozapine: The interesting association
  7. Stimulants and Cannabis Use Among a Marginalized Population in British Columbia, Canada
  8. Impulsivity in remitted depression: A meta-analytical review
  9. Family History of Alcohol and Drug Abuse, Childhood Trauma, and Age of First Drug Injection
  10. Homeless and incarcerated: An epidemiological study from Canada
  11. The ball always bounces equally in both courts: Ethics and equal responsibilities of editors and authors
  12. Clinical Practice Guidelines in Psychiatry: More Confusion Than Clarity? A Critical Review and Recommendation of a Unified Guideline
  13. Amisulpride Treatment of Somatoform Disorders
  14. Gender differences in early trauma and high-risk behaviors among street-entrenched youth in British Columbia
  15. Online interventions for depression and anxiety – a systematic review
  16. Mirtazapine associated tender pitting pedal oedema
  17. Is exposure to childhood maltreatment associated with adult psychological distress among adult intravenous drug user?
  18. Tardive Oculogyric Crisis Associated With Quetiapine Use
  19. Quality of Life and Marital Adjustment in Remitted Psychiatric Illness
  20. Acute Delirium due to Parenteral Tramadol
  21. The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions
  22. Aripiprazole Associated With Acute Dystonia, Akathisia, and Parkinsonism in a Single Patient
  23. Psychiatric comorbidity and gender differences among suicide attempters in Bangalore, India
  24. Client Satisfaction with HIV Counseling Services
  25. Poster #215 PREHYPERTENSION, HYPERTENSION, DIABETES, OBESITY AND CARDIOMETABOLIC CHANGES ASSOCIATED WITH ANTIPSYCHOTIC USE IN SCHIZOPHRENIA
  26. Sapophagia (Compulsive Soap Eating) and Attention-Deficit/Hyperactivity Disorder in a Child Responsive to Clonidine
  27. Can't Sleep? Issues of Being an Insomniac
  28. Orthorexia nervosa presenting as prodrome of schizophrenia
  29. Suicides versus attempted suicides: What is the truth in the numbers?
  30. Atypical presentation of tuberous sclerosis and obsessive compulsive disorder in an adult male
  31. Baclofen-Induced Morbiliform Rashes: A Case series
  32. Antipsychotic use associated with metabolic & weight changes in schizophrenia
  33. Hypertension, diabetes and cardiometabolic changes associated with antipsychotic use in schizophrenia
  34. Amisulpride in the Treatment of Somatoform Disorders
  35. Koro: Culture Bound or Mass Hysteria?
  36. Prevention of Alcohol Dependence: Strategies for Selective, Indicated, and Universal Prevention
  37. A Case of Obsessive-Compulsive Disorder Presenting as Dissociative Disorder
  38. Craving for Drugs and Satiety
  39. Behavioral Emergencies in India: Would Psychiatric Emergency Services Help?
  40. De Novo Dose-Dependent Catatonia Due to Disulfiram Therapy: A Report and Review
  41. Universal mental health program: An extension of life skills education to promote child mental health
  42. Prevalence of Depression, Anxiety, and Stress Among Young Male Adults in India
  43. Pre-hospital determinants of outcome in traumatic brain injury: Experiences from first comprehensive integrated pre-hospital care providers in India: GVK — EMRI Experience
  44. First rank symptoms: concepts and diagnostic utility
  45. Legislative control of alcohol use: Is it an unmet need of public health policy? Recommendations for India and other developing nations
  46. Perceived Reasons for and Consequences of Substance Abuse Among Patients With Psychosis
  47. Schizo-obsession as probable temporal lobe epilepsy phenomenon
  48. The burden of behavioral emergencies: need for specialist emergency services
  49. Disease Mongering in Psychiatry: Is It Fact or Fiction?
  50. Attempted Suicides in India: A Comprehensive Look
  51. How Is Substance Use Linked to Psychosis? A Study of the Course and Patterns of Substance Dependence in Psychosis
  52. Diagnosis and treatment of chronic insomnia
  53. Clinical course of development of alcohol and opioid dependence: What are the implications in prevention?
  54. Why do we need to control alcohol use through legislative measures? A south east asia perspective?
  55. Prevalence of Tobacco Use among Young Adult Males in India: A Community-Based Epidemiological Study
  56. Metabolic syndrome in mental illness: evidence and way out
  57. Medical emergencies in Goa
  58. Is 47 XXY the Genetic Marker for Aicardi Syndrome?
  59. Is the male Aicardi's characterized by 46 XXY karyotype?
  60. Clinical Antipsychotic Trials of Intervention Effectiveness Study
  61. Behavioral emergencies in India: a population based epidemiological study
  62. Antipsychotic-induced urinary dysfunction: anticholinergic effect or otherwise?
  63. Is every chest pain a cardiac event?
  64. Possible manic switch induced by combination of bupropion and electroconvulsive therapy in recurrent unipolar depression: a case series
  65. Neurological Emergencies in India – Lessons Learnt and Strategies to Improve Outcomes
  66. Emergency medical epidemiology in Assam, India
  67. Delusion of pregnancy associated with antipsychotic induced metabolic syndrome
  68. Little difference between haloperidol, risperidone and olanzapine in weight gain after 1 year of treatment
  69. Erratum to “Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study” [Schizophrenia Research 101 (2008) 266­272]
  70. Attitudes of Ward Attendants Towards Mental Illness: Comparisons and Predictors
  71. Who decides on treatment for mental illness?
  72. Delayed-onset delirium tremens – a diagnostic and management challenge
  73. Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia
  74. Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study
  75. Alzheimer's and Non-Alzheimer's Dementia: A Critical Review of Pharmacological and Nonpharmacological Strategies
  76. Prevalence of depression, stress, and anxiety among tobacco-using male college students in Ranchi and the relationship with cotinine in the body
  77. 105 – Course and patterns of substance dependence in psychosis
  78. Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis
  79. Chronology of alcohol dependence: Implications in prevention
  80. Assessment of Mood and Affect by Mental State Examination in Different Cultural Contexts
  81. Is Psychosocial Management Effective?
  82. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report
  83. Typical Aicardi syndrome in a male
  84. Risperidone-induced recurrent giant urticaria
  85. Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: A six-week prospective study in Indian female patients
  86. The Role of Gateway Drugs and Psychosocial Factors in Substance Dependence in Eastern India
  87. Diagnostic confusion ? EOS or frontal dementia
  88. Idiopathic Recurrent Catatonia Needs Maintenance Lorazepam: Case Report and Review
  89. Chloroquine-Induced Recurrent Psychosis
  90. Letter to the editor
  91. Acute Nocturnal Akathisia Induced By Clozapine
  92. Clozapine-induced angioneurotic edema
  93. Management of treatment-resistant obsessive-compulsive disorder: An update on therapeutic strategies
  94. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine
  95. Why is alcohol excluded and opium included in NDPS act, 1985?